deeptech Value proposition
goes FAR BEYOND
(Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases)
Dimicare Biotech is a project from INSERM and Université Côte d'Azur focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed.
Dimicare Biotech is building a great team involving Microbiology Medical doctors, Fundamental researchers, and Financial experts, assuring solid growth not only in the scientific but also in the business field.
Currently, our projects have been awarded by the Innovation program from Labex SIGNALIFE (Young Entrepreneur Program) and we are currently searching for new funding to support the continuity of the project.
If you are interested in our research and want to contact us for collaboration or just to talk, do not hesitate to contact me through any of the options available in my profile.
Microbiology, Antimicrobial Resistance, Bacteria, Fungi, Parasites, Drug Development, and Medicinal ChemistryOriginal language
goes FAR BEYOND
(Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases)
Dimicare Biotech is a project from INSERM and Université Côte d'Azur focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed.
Dimicare Biotech is building a great team involving Microbiology Medical doctors, Fundamental researchers, and Financial experts, assuring solid growth not only in the scientific but also in the business field.
Currently, our projects have been awarded by the Innovation program from Labex SIGNALIFE (Young Entrepreneur Program) and we are currently searching for new funding to support the continuity of the project.
If you are interested in our research and want to contact us for collaboration or just to talk, do not hesitate to contact me through any of the options available in my profile.
Home
Antibiotics, Resistance, Precision treatment, emergent pathogen, infectious disease, Drug Discovery, Biotech, HealthTech, Innovation, Research, Microbiology, Pharmacology, Infection,
https://www.dimicare-biotech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 10 Jul 2024 | | |
 | Rise Partners | Other 22 Jan 2024 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 16 Feb 2024 | | |
 Caisse d’Epargne Banking | Caisse d’Epargne Banking | Other 22 Jan 2024 | | |
 Inria Research, Research Services | Inria Research, Research Services | Other 22 Jan 2024 | | |
 Orange Telecoms, Law Practice, Telecommunications | Orange Telecoms, Law Practice, Telecommunications | Other 22 Jan 2024 | | |
 INIZIÀ - Incubateur Territorial des Entreprises Innovantes de Corse Business Consulting and Services | INIZIÀ - Incubateur Territorial des Entreprises Innovantes de Corse Business Consulting and Services | Other 19 Oct 2023 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 14 Oct 2023 | | |